title: Birth weight and cardiovascular risk factors in a cohort followed until 80 years of age: the study of men born in 1913.
abstract: OBJECTIVE
  To analyse whether there is a relation-ship between birth weight and cardiovascular risk factors given the influence of potential modifying factors from birth time, former generations and adult life.
  
  
  METHODS
  Population-based cohort followed until 80 years of age.
  
  
  METHODS
  Sweden.
  
  
  METHODS
  A total of 478 singleton men born in 1913 and participating in a population study in Gothenburg, Sweden, from age 50.
  
  
  METHODS
  Systolic blood pressure (SBP), antihypertensive treatment, incident diabetes mellitus, and serum total cholesterol, serum triglycerides and waist circumference as both continuous variables and in the highest quintiles of their distributions.
  
  
  RESULTS
  After adjustment for the influence of birth time variables, hereditary factors and anthropometric and socio-economic adult life variables, SBP decreased by 3.7 mmHg per 1000 g increase of birth weight, the prevalence of antihypertensive treatment decreased by 32%, diabetes decreased by 53%, serum total cholesterol decreased by 0.20 mmol L(-1) and being in the top quintile of serum cholesterol decreased by 23%. The population risk percentage due to a birth weight < or =3000 g was for all three outcomes 3.8% and for antihypertensive treatment, diabetes and cholesterol 0.2, 18 and 2.5%, respectively.
  
  
  CONCLUSIONS
  Low birth weight thus seems to affect the development of increasing SBP, antihypertensive treatment, diabetes and high cholesterol even when potential effect modifiers from birth time, former generations and adult life were taken into account. In the general population, the risk percentage due to a birth weight < or =3000 g was largest for diabetes.
authors.affiliation: Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology Section, Uppsala University, Uppsala, Sweden. margaretha.eriksson@pubcare.uu.se
authors.forename: M
authors.initials: M
authors.lastname: Eriksson
authors.forename: M-A
authors.initials: MA
authors.lastname: Wallander
authors.forename: I
authors.initials: I
authors.lastname: Krakau
authors.forename: H
authors.initials: H
authors.lastname: Wedel
authors.forename: K
authors.initials: K
authors.lastname: Svärdsudd
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000886:Anthropometry; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001724:Birth Weight; D001794:Blood Pressure; D001824:Body Constitution; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology*; D002784:Cholesterol / Q000097:blood; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012959:Socioeconomic Factors; D013548:Sweden / Q000453:epidemiology; D014280:Triglycerides / Q000097:blood
chemical_list: D000959:Antihypertensive Agents; D014280:Triglycerides; D002784:Cholesterol